Not Tagged
Not Tagged
['solid tumor']
at #asco2023, , an #immunotherapy fellow working with , presented their phase i/ii study of star0602, a novel selective t-cell receptor-targeting bifunctional antibody as a therapy in antigen-rich solid tumors post checkpoint inhibitor treatment. 
Highlighting clinical research in Medical Oncology at CCR/NCI. Official Twitter account of the NCI MOS. Privacy: https://t.co/gFvBNAjaVl